Tharimmune, Inc. announced the filing of a PRE 14A preliminary proxy statement with the SEC, scheduling its annual meeting of stockholders for May 2024. The meeting will address the election of five board members, the ratification of Rosenberg Rich Baker Berman P.A. as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of the Amended and Restated 2023 Omnibus Equity Incentive Plan. Additionally, the board will seek discretionary authority to amend the company's Certificate of Incorporation to effect a reverse stock split of the issued and outstanding shares of common stock, with a proposed ratio range from 1-for-2 up to 1-for-50, to be completed by May 2025. The reverse stock split aims to increase the per...Show More

Tharimmune, Inc. announced the filing of a PRE 14A preliminary proxy statement with the SEC, scheduling its annual meeting of stockholders for May 2024. The meeting will address the election of five board members, the ratification of Rosenberg Rich Baker Berman P.A. as the independent registered public accounting firm for the fiscal year ending December 31, 2024, and the approval of the Amended and Restated 2023 Omnibus Equity Incentive Plan. Additionally, the board will seek discretionary authority to amend the company's Certificate of Incorporation to effect a reverse stock split of the issued and outstanding shares of common stock, with a proposed ratio range from 1-for-2 up to 1-for-50, to be completed by May 2025. The reverse stock split aims to increase the per-share price of Tharimmune's common stock to comply with Nasdaq's minimum bid price requirement and to make the stock more attractive to investors. The meeting will also cover other business as may arise. The record date for stockholders entitled to vote has been set for March 2024, with registration beginning at 8:30 a.m. EST on the day of the meeting.